 | • レポートコード：QYR2104Z3377 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、潜在性結核感染症（LTBI）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ツベルクリン皮膚検査（TST）、インターフェロンガンマ放出アッセイ（IGRA））、用途別市場規模（病院・クリニック、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・潜在性結核感染症（LTBI）検査の市場動向 ・企業の競争状況、市場シェア ・潜在性結核感染症（LTBI）検査の種類別市場規模（ツベルクリン皮膚検査（TST）、インターフェロンガンマ放出アッセイ（IGRA）） ・潜在性結核感染症（LTBI）検査の用途別市場規模（病院・クリニック、診断研究所、その他） ・潜在性結核感染症（LTBI）検査の北米市場規模2016-2027（アメリカ、カナダ） ・潜在性結核感染症（LTBI）検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・潜在性結核感染症（LTBI）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・潜在性結核感染症（LTBI）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・潜在性結核感染症（LTBI）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Qiagen、Sanofi、Oxford Immunotec、Thermo Fisher Scientific、Par Sterile、Bio-Rad Laboratories） ・結論 |
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
Market Analysis and Insights: Global Latent Tuberculosis Infection (LTBI) Testing Market
The global Latent Tuberculosis Infection (LTBI) Testing market size is projected to reach US$ 1815.9 million by 2026, from US$ 1264.4 million in 2019, at a CAGR of 5.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Latent Tuberculosis Infection (LTBI) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Latent Tuberculosis Infection (LTBI) Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Latent Tuberculosis Infection (LTBI) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Latent Tuberculosis Infection (LTBI) Testing market.
Global Latent Tuberculosis Infection (LTBI) Testing Scope and Market Size
Latent Tuberculosis Infection (LTBI) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Latent Tuberculosis Infection (LTBI) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2016-2027)
2.2 Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Historic Market Share by Regions (2016-2021)
2.2.3 Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Regions (2022-2027)
2.3 Latent Tuberculosis Infection (LTBI) Testing Industry Dynamic
2.3.1 Latent Tuberculosis Infection (LTBI) Testing Market Trends
2.3.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
2.3.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges
2.3.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2016-2021)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2016-2021)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
3.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2020
3.5 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
3.6 Key Players Latent Tuberculosis Infection (LTBI) Testing Product Solution and Service
3.7 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2016-2021)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2022-2027)
5 Latent Tuberculosis Infection (LTBI) Testing Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2016-2021)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2016-2027)
6.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
6.2.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021)
6.2.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027)
6.2.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2027)
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
6.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021)
6.3.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027)
6.3.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2027)
6.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
6.4.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021)
6.4.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2016-2027)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
7.2.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021)
7.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027)
7.2.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2027)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
7.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021)
7.3.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027)
7.3.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2027)
7.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
7.4.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021)
7.4.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size (2016-2027)
8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
8.2.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
8.3.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
8.4.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size (2016-2027)
9.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
9.2.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021)
9.2.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027)
9.2.3 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2027)
9.3 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
9.3.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021)
9.3.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027)
9.3.3 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2027)
9.4 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
9.4.1 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021)
9.4.2 Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size (2016-2027)
10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
10.2.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
10.3.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
10.4.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
11.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
11.1.5 Qiagen Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction
11.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Oxford Immunotec
11.3.1 Oxford Immunotec Company Details
11.3.2 Oxford Immunotec Business Overview
11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction
11.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
11.3.5 Oxford Immunotec Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Par Sterile
11.5.1 Par Sterile Company Details
11.5.2 Par Sterile Business Overview
11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction
11.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
11.5.5 Par Sterile Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tuberculin Skin Test (TST)
Table 3. Key Players of Interferon Gamma Released Assay (IGRA)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2016-2021)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2022-2027)
Table 10. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Table 11. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Table 12. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 13. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players (2016-2021)
Table 16. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2020)
Table 17. Ranking of Global Top Latent Tuberculosis Infection (LTBI) Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Latent Tuberculosis Infection (LTBI) Testing Product Solution and Service
Table 21. Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Qiagen Company Details
Table 62. Qiagen Business Overview
Table 63. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product
Table 64. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021) & (US$ Million)
Table 65. Qiagen Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product
Table 69. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Oxford Immunotec Company Details
Table 72. Oxford Immunotec Business Overview
Table 73. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product
Table 74. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021) & (US$ Million)
Table 75. Oxford Immunotec Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product
Table 79. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Par Sterile Company Details
Table 82. Par Sterile Business Overview
Table 83. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product
Table 84. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021) & (US$ Million)
Table 85. Par Sterile Recent Development
Table 86. Bio-Rad Laboratories Company Details
Table 87. Bio-Rad Laboratories Business Overview
Table 88. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product
Table 89. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021) & (US$ Million)
Table 90. Bio-Rad Laboratories Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2020 VS 2027
Figure 2. Tuberculin Skin Test (TST) Features
Figure 3. Interferon Gamma Released Assay (IGRA) Features
Figure 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Diagnostic Laboratories Case Studies
Figure 7. Others Case Studies
Figure 8. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2022-2027)
Figure 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2020
Figure 14. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2020
Figure 16. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2016-2027)
Figure 20. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2016-2027)
Figure 21. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2016-2027)
Figure 22. United States Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2016-2027)
Figure 26. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2016-2027)
Figure 27. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2016-2027)
Figure 28. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Share by Region (2016-2027)
Figure 38. China Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2016-2027)
Figure 46. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2016-2027)
Figure 47. Latin America Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2016-2027)
Figure 48. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Share by Country (2016-2027)
Figure 54. Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Latent Tuberculosis Infection (LTBI) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
Figure 58. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
Figure 59. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
Figure 61. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の結核感染検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Infection Testing Market The global Tuberculosis Infection Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…- 世界の結核診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnostic Market The global Tuberculosis Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の結核診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tuberculosis Diagnostic Market The global Tuberculosis Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の院内感染性尿路感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital-acquired Urinary Tract Infection Testing Market The global Hospital-acquired Urinary Tract Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard …
- 世界の菌血症検査市場規模・現状・予測（2021年-2027年） BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections. Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests …